Histogen Statistics
Total Valuation
Histogen has a market cap or net worth of $1.50 million. The enterprise value is -$3.08 million.
| Market Cap | 1.50M |
| Enterprise Value | -3.08M |
Important Dates
The last earnings date was Thursday, November 9, 2023, after market close.
| Earnings Date | Nov 9, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
Histogen has 4.27 million shares outstanding. The number of shares has increased by 20.17% in one year.
| Shares Outstanding | 4.27M |
| Shares Change (YoY) | +20.17% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.85% |
| Owned by Institutions (%) | 5.25% |
| Float | 3.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 78.69 |
| Forward PS | n/a |
| PB Ratio | 0.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.05, with zero debt.
| Current Ratio | 4.05 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 12,079.00 |
Financial Efficiency
Return on equity (ROE) is -228.22% and return on invested capital (ROIC) is -221.76%.
| Return on Equity (ROE) | -228.22% |
| Return on Assets (ROA) | -213.27% |
| Return on Capital (ROIC) | -221.76% |
| Revenue Per Employee | $2,714 |
| Profits Per Employee | -$1.77M |
| Employee Count | 7 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.16% in the last 52 weeks. The beta is 1.17, so Histogen's price volatility has been higher than the market average.
| Beta (1Y) | 1.17 |
| 52-Week Price Change | -63.16% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 0.48 |
| Relative Strength Index (RSI) | 44.57 |
| Average Volume (30 Days) | 18,341 |
Short Selling Information
The latest short interest is 67,030, so 1.57% of the outstanding shares have been sold short.
| Short Interest | 67,030 |
| Short Previous Month | 40,166 |
| Short % of Shares Out | 1.57% |
| Short % of Float | 1.71% |
| Short Ratio (days to cover) | 4.25 |
Income Statement
In the last 12 months, Histogen had revenue of $19,000 and -$12.41 million in losses. Loss per share was -$3.13.
| Revenue | 19,000 |
| Gross Profit | 19,000 |
| Operating Income | -12.06M |
| Pretax Income | -12.38M |
| Net Income | -12.41M |
| EBITDA | -11.94M |
| EBIT | -12.08M |
| Loss Per Share | -$3.13 |
Balance Sheet
The company has $4.57 million in cash and no debt, giving a net cash position of $4.57 million or $1.07 per share.
| Cash & Cash Equivalents | 4.57M |
| Total Debt | n/a |
| Net Cash | 4.57M |
| Net Cash Per Share | $1.07 |
| Equity / Book Value | 5.44M |
| Book Value Per Share | 1.27 |
| Working Capital | 4.11M |
Cash Flow
In the last 12 months, operating cash flow was -$10.07 million and capital expenditures -$1,000, giving a free cash flow of -$10.08 million.
| Operating Cash Flow | -10.07M |
| Capital Expenditures | -1,000 |
| Free Cash Flow | -10.08M |
| FCF Per Share | -$2.36 |
Margins
Gross margin is 100.00%, with operating and profit margins of -63,447.37% and -65,294.74%.
| Gross Margin | 100.00% |
| Operating Margin | -63,447.37% |
| Pretax Margin | -65,178.95% |
| Profit Margin | -65,294.74% |
| EBITDA Margin | -62,847.37% |
| EBIT Margin | -63,573.68% |
| FCF Margin | -53,026.32% |
Dividends & Yields
Histogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.17% |
| Shareholder Yield | -20.17% |
| Earnings Yield | -829.77% |
| FCF Yield | -673.86% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 3, 2022. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 3, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
Histogen has an Altman Z-Score of -28.88 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.88 |
| Piotroski F-Score | 1 |